1 |
Rosetti B, Marchesan S. Peptide Inhibitors of Insulin Fibrillation: Current and Future Challenges. Int J Mol Sci 2023;24. [PMID: 36674821 DOI: 10.3390/ijms24021306] [Reference Citation Analysis]
|
2 |
Lu SS, Lai Y, Hsiao L, Huang H, Tsai Y, Chen Y, Wang SS, Yeh Y, Tsai S. Effects of Amino Acid-Functionalized Silver Nanoparticles on Lysozyme Amyloid Fibrillogenesis. Colloids and Surfaces B: Biointerfaces 2023. [DOI: 10.1016/j.colsurfb.2023.113144] [Reference Citation Analysis]
|
3 |
Yamamoto N, Inoue R, Makino Y, Sekiguchi H, Shibayama N, Naito A, Sugiyama M, Chatani E. Tracking the Structural Development of Amyloid Precursors in the Insulin B Chain and the Inhibition Effect by Fibrinogen. J Phys Chem B 2022;126:10797-812. [PMID: 36534755 DOI: 10.1021/acs.jpcb.2c05136] [Reference Citation Analysis]
|
4 |
Qafary M, Rashno F, Khajeh K, Khaledi M, Moosavi-movahedi AA. Insulin fibrillation: Strategies for inhibition. Progress in Biophysics and Molecular Biology 2022. [DOI: 10.1016/j.pbiomolbio.2022.09.001] [Reference Citation Analysis]
|
5 |
Dzhagan V, Pirko Y, Buziashvili A, Plokhovska S, Borova M, Yemets A, Mazur N, Kapush O, Yukhymchuk V. Контрольована агрегація плазмонних наночастинок для підвищення ефективності SERS-підкладок. Ukr J Phys 2022;67:80. [DOI: 10.15407/ujpe67.1.80] [Reference Citation Analysis]
|